FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle
BackgroundDiabetic nephropathy (DN) is a prevalent global renal illness and one of the main causes of end-stage renal disease (ESRD). FGF21 has been shown to ameliorate diabetic nephropathy, and in addition FGF-21-treated mice impeded mitogenicity, whereas it is unclear whether FGF21 can influence D...
Saved in:
Main Authors: | Yudie Zhang, Fan Wang, Chongyang Zhang, Fan Yao, Bin Zhang, Yongping Zhang, Xiaobo Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1500458/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating FGF21 is lower in South Asians compared with Europids with type 2 diabetes mellitus
by: Carlijn A Hoekx, et al.
Published: (2025-01-01) -
FGF21 acts in the brain to drive macronutrient-specific changes in behavioral motivation and brain reward signaling
by: Md Shahjalal H. Khan, et al.
Published: (2025-01-01) -
Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple‐Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1‐Regulated Cholesterol Metabolism
by: Yilan Yang, et al.
Published: (2025-02-01) -
Estradiol-dependent and independent effects of FGF21 in obese female mice
by: T. V. Jakovleva, et al.
Published: (2022-04-01) -
GPX4 expression changes in proximal tubule cells highlight the role of ferroptosis in IgAN
by: Jianbo Qing, et al.
Published: (2025-01-01)